Skip to main content
editorial
. 2017 Jul 1;3(3):128–139.

Table 1.

Characteristics of MSM by intention to initiate nPEP

Characteristics Did not intend to initiate nPEP Intended to initiate nPEP Total P-value
n=269 n=181 n=450
Age(years), mean(SD) 26.9(6.1) 26.5(6.2) 26.8(6.1) 0.33
Highest level of education, n(%)
 Lower than high school 14(5.2) 3(1.7) 17(3.8) 0.21
 High school/basic technical school 60(22.3) 46(25.4) 106(23.6)
 Advanced technical school/associate degree 16(6.0) 8(4.4) 24(5.3)
 Bachelor's degree or higher 176(66.5) 124(68.5) 303(67.3)
Current occupation, n(%)
 Not working/student 99(36.9) 78(43.3) 177(39.5) 0.42
 Company or government employee 126(47.0) 83(46.1) 209(46.7)
 Private business/merchant 34(12.7) 16(8.9) 50(11.2)
 Other 9(3.4) 3(1.7) 12(2.7)
 No data 1(0.4) 1(0.6) 2(0.4)
Income(USD/month), median(IQR),(min–max) 428.6(257.1–742.9), (0–600,000) 428.6(257.1–628.6), (0–120,000) 428.6(257.1–714.3), (0–600,000) 0.73
Prior awareness of nPEP, n(%) 150(55.8) 121(66.9) 271(60.2) 0.02
Prior experience of nPEP, n(%)
 No 254(94.4) 163(90.1) 417(92.1) 0.04
 Not sure 2(0.7) 0 2(0.4)
 Yes 12(4.5) 18(9.9) 30(6.9)
  • No side effects 0 1(5.6) 1(3.2)
  • Gastrointestinal discomfort 10(76.9) 13(72.2) 23(74.2)
  • Headache/dizziness 11(84.6) 18(100.0) 29(93.6)
  • Rash 3(23.1) 0 3(9.7)
  • Hepatitis 1(7.7) 1(5.6) 2(6.5)
  • Others 4(30.8) 1(5.6) 5(16.1)
Reason not to take nPEP in the past(n=414), n(%)
  • No risk 130(51.6) 87(53.7) 217(52.4) 0.88
  • Risk exceeding 72 hours 102(40.5) 60(37.0) 162(39.1)
  • Risk within 72 hours but was not advised by counsellor to take nPEP 19(7.5) 14(8.6) 33(8.0)
  • Personal reasons 1(0.4) 1(0.6) 2(0.5)
HIV status at screening visit, n(%)
 Inconclusive 0 1(0.56) 1(0.2) 0.71
 Negative 212(78.8) 145(80.1) 357(79.3)
 Positive 53(19.7) 32(17.7) 85(18.9)
 Decided not to test 4(1.5) 3(1.7) 7(1.6)

nPEP: non-occupational post-exposure prophylaxis; USD=US dollar